Literature DB >> 7854126

The colicin A pore-forming domain fused to mitochondrial intermembrane space sorting signals can be functionally inserted into the Escherichia coli plasma membrane by a mechanism that bypasses the Tol proteins.

D Espesset1, Y Corda, K Cunningham, H Bénedetti, R Lloubès, C Lazdunski, V Géli.   

Abstract

Colicin A is a pore-forming bacteriocin that depends upon the Tol proteins in order to be transported from its receptor at the outer membrane surface to its target, the inner membrane. The presequence of yeast mitochondria cytochrome c1 (pc1) as well as the first 167 amino acids of cytochrome b2 (pb2) were fused to the pore-forming domain of colicin A (pfColA). Both hybrid proteins (pc1-pfCoIA and pb2-pfColA) were cytotoxic for Escherichia coli strains devoid of colicin A immunity protein whereas the pore-forming domain without presequence had no lethal effect. The entire precursors and their processed forms were found entirely associated with the bacterial inner membrane and their cytotoxicities were related to their pore-forming activities. The proteins were also shown to kill the tol bacterial strains, which are unable to transport colicins. In addition, we showed that both the cytochrome c1 presequence fused to the dihydrofolate reductase (pc1-DHFR) and the cytochrome c1 presequence moiety of pc1-pfCoIA were translocated across inverted membrane vesicles. Our results indicated that: (i) pc1-pfCoIA produced in the cell cytoplasm was able to assemble in the inner membrane by a mechanism independent of the tol genes; (ii) the inserted pore-forming domain had a channel activity; and (iii) this channel activity was inhibited within the membrane by the immunity protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7854126     DOI: 10.1111/j.1365-2958.1994.tb00503.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.

Authors:  R Voulhoux; G Ball; B Ize; M L Vasil; A Lazdunski; L F Wu; A Filloux
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Colicin A immunity protein interacts with the hydrophobic helical hairpin of the colicin A channel domain in the Escherichia coli inner membrane.

Authors:  A Nardi; Y Corda; D Baty; D Duché
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

Review 3.  Colicin import into Escherichia coli cells.

Authors:  C J Lazdunski; E Bouveret; A Rigal; L Journet; R Lloubès; H Bénédetti
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

4.  The channel domain of colicin A is inhibited by its immunity protein through direct interaction in the Escherichia coli inner membrane.

Authors:  D Espesset; D Duché; D Baty; V Géli
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

5.  Pectocin M1 (PcaM1) Inhibits Escherichia coli Cell Growth and Peptidoglycan Biosynthesis through Periplasmic Expression.

Authors:  Dimitri Chérier; Sean Giacomucci; Delphine Patin; Ahmed Bouhss; Thierry Touzé; Didier Blanot; Dominique Mengin-Lecreulx; Hélène Barreteau
Journal:  Antibiotics (Basel)       Date:  2016-10-08

Review 6.  Colicin biology.

Authors:  Eric Cascales; Susan K Buchanan; Denis Duché; Colin Kleanthous; Roland Lloubès; Kathleen Postle; Margaret Riley; Stephen Slatin; Danièle Cavard
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

7.  Dual expression profile of type VI secretion system immunity genes protects pandemic Vibrio cholerae.

Authors:  Sarah T Miyata; Daniel Unterweger; Sydney P Rudko; Stefan Pukatzki
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

8.  High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.

Authors:  Matthias J H Gerritzen; Ronald H W Maas; Jan van den Ijssel; Lonneke van Keulen; Dirk E Martens; René H Wijffels; Michiel Stork
Journal:  Microb Cell Fact       Date:  2018-10-03       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.